Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2024 Filed Jun 5, 2024 21:10 UTC |
RIKER LAURENSenior Vice President, Finance
|
Tax withholdingCommon Stock | 1,843 | $30.89 | $56,930.27 |
DisclosureSEC source: 0001396814-24-000055 · wk-form4_1717621792.xml · nonDerivative · entry 1 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,685.335 F1 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:09 UTC |
GAUGLER DARYLChief Operating Officer
|
Tax withholdingCommon Stock | 2,754 | $30.89 | $85,071.06 |
DisclosureSEC source: 0001396814-24-000052 · wk-form4_1717621751.xml · nonDerivative · entry 1 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,739.584 F1 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| March 08, 2024 Filed Mar 8, 2024 22:33 UTC |
PACE GARY WDirector
|
SaleCommon Stock | 90,000 | $30.60 | $2,754,000.00 |
DisclosureSEC source: 0001396814-24-000037 · wk-form4_1709937219.xml · nonDerivative · entry 3 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,127 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.300 to $30.860, inclusive. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:33 UTC |
PACE GARY WDirector
|
SaleCommon Stock | 28,257 | $30.81 | $870,598.17 |
DisclosureSEC source: 0001396814-24-000037 · wk-form4_1709937219.xml · nonDerivative · entry 2 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,127 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.550 to $30.965, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 2. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:33 UTC |
PACE GARY WDirector
|
SaleCommon Stock | 1,066 | $29.67 | $31,628.22 |
DisclosureSEC source: 0001396814-24-000037 · wk-form4_1709937219.xml · nonDerivative · entry 1 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,384 Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 21:59 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
GrantCommon Stock | 33,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000018 · wk-form4_1707343183.xml · nonDerivative · entry 1 WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,075 F1 · shares: Represents restricted stock units that vest on February 1, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 21:59 UTC |
GAUGLER DARYLChief Operating Officer
|
GrantCommon Stock | 33,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000017 · wk-form4_1707343168.xml · nonDerivative · entry 1 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,493.584 F1 · shares: Represents restricted stock units that vest on February 1, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. F2 · balance_after: Includes 135.988 shares of common stock acquired under the issuer's employee stock purchase plan in December 2023. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:24 UTC |
SLONIN JONATHANChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $32.07 | $0.00 |
DisclosureSEC source: 0001396814-24-000013 · wk-form4_1704407065.xml · derivative · entry 2 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-01-03 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:21 UTC |
Lee Frank D.Director · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 692,512 | $0.00 Strike: $32.07 | $0.00 |
DisclosureSEC source: 0001396814-24-000012 · wk-form4_1704406869.xml · derivative · entry 2 Lee Frank D. · CIK 0001814686 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 692,512 Underlying: Common Stock · 692,512 shares Expires 2034-01-03 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:24 UTC |
SLONIN JONATHANChief Medical Officer
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000013 · wk-form4_1704407065.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,196.475 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on January 2, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. F2 · balance_after: Includes 311.535 shares of common stock acquired under the issuer's employee stock purchase plan in December 2023. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:25 UTC |
RIKER LAURENSenior Vice President, Finance
|
Tax withholdingCommon Stock | 159 | $32.00 | $5,088.00 |
DisclosureSEC source: 0001396814-24-000014 · wk-form4_1704407150.xml · nonDerivative · entry 1 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,528.335 F1 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:21 UTC |
Lee Frank D.Director · Chief Executive Officer
|
GrantCommon Stock | 99,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000012 · wk-form4_1704406869.xml · nonDerivative · entry 1 Lee Frank D. · CIK 0001814686 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,520 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on January 2, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| October 06, 2023 Filed Oct 11, 2023 20:47 UTC |
Young AlethiaDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,967 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001396814-23-000073 · wk-form4_1697057217.xml · derivative · entry 1 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,967 Underlying: Common Stock · 30,967 shares Expires 2033-10-06 F1 · derivative.exercise_date: The options vest in 36 equal successive monthly installments over the 36-month period following the date of grant, subject to the reporting person's continued service as a director. Read SEC document |
| October 06, 2023 Filed Oct 11, 2023 20:46 UTC |
YANG MICHAEL J.Director
|
GrantStock Option (Right to Buy) · Derivative | 30,967 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001396814-23-000072 · wk-form4_1697057204.xml · derivative · entry 1 YANG MICHAEL J. · CIK 0001702283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,967 Underlying: Common Stock · 30,967 shares Expires 2033-10-06 F1 · derivative.exercise_date: The options vest in 36 equal successive monthly installments over the 36-month period following the date of grant, subject to the reporting person's continued service as a director. Read SEC document |
| October 06, 2023 Filed Oct 11, 2023 20:46 UTC |
BIGAL MARCELODirector
|
GrantStock Option (Right to Buy) · Derivative | 30,967 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001396814-23-000071 · wk-form4_1697057191.xml · derivative · entry 1 BIGAL MARCELO · CIK 0001996637 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,967 Underlying: Common Stock · 30,967 shares Expires 2033-10-06 F1 · derivative.exercise_date: The options vest in 36 equal successive monthly installments over the 36-month period following the date of grant, subject to the reporting person's continued service as a director. Read SEC document |
| October 06, 2023 Filed Oct 11, 2023 20:46 UTC |
Ceesay AbrahamDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,967 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001396814-23-000070 · wk-form4_1697057179.xml · derivative · entry 1 Ceesay Abraham · CIK 0001722140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,967 Underlying: Common Stock · 30,967 shares Expires 2033-10-06 F1 · derivative.exercise_date: The options vest in 36 equal successive monthly installments over the 36-month period following the date of grant, subject to the reporting person's continued service as a director. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:47 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 509 | $34.88 | $17,751.38 |
DisclosureSEC source: 0001396814-23-000041 · wk-form4_1691182061.xml · nonDerivative · entry 1 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,440.335 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 643.335 shares of common stock acquired under the issuer's employee stock purchase plan in June 2023. Read SEC document |
| July 05, 2023 Filed Jul 8, 2023 00:04 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 643 | $38.91 | $25,019.13 |
DisclosureSEC source: 0001209191-23-041865 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,687.335 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.67 to $39.40, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes 643.335 shares of common stock acquired under the issuer's employee stock purchase plan in June 2023. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:30 UTC |
Froimson MarkDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,925 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038020 · doc4.xml · derivative · entry 2 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,925 Underlying: Common Stock · 12,925 shares Expires 2033-06-14 Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:30 UTC |
Froimson MarkDirector
|
GrantCommon Stock | 1,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038020 · doc4.xml · nonDerivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,843 F1 · shares: Represents restricted stock units that vest on June 3, 2024, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:38 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038028 · doc4.xml · derivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2033-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:38 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038028 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,626 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:42 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
GrantStock Option (Right to Buy) · Derivative | 27,500 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038032 · doc4.xml · derivative · entry 3 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires 2033-06-14 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:42 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 6,467 | $37.03 | $239,473.01 |
DisclosureSEC source: 0001209191-23-038032 · doc4.xml · nonDerivative · entry 2 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,375 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:42 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
GrantCommon Stock | 10,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038032 · doc4.xml · nonDerivative · entry 1 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,842 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:40 UTC |
STACK DAVID MDirector · CEO and Chairman
|
GrantStock Option (Right to Buy) · Derivative | 245,400 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038031 · doc4.xml · derivative · entry 5 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,400 Underlying: Common Stock · 245,400 shares Expires 2033-06-14 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:40 UTC |
STACK DAVID MDirector · CEO and Chairman
|
GrantCommon Stock | 32,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038031 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,481 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:36 UTC |
PACE GARY WDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,925 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038025 · doc4.xml · derivative · entry 2 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,925 Underlying: Common Stock · 12,925 shares Expires 2033-06-14 Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:36 UTC |
PACE GARY WDirector
|
GrantCommon Stock | 1,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038025 · doc4.xml · nonDerivative · entry 1 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,450 F1 · shares: Represents restricted stock units that vest on June 3, 2024, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:32 UTC |
HASTINGS PAUL JDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,925 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038023 · doc4.xml · derivative · entry 2 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,925 Underlying: Common Stock · 12,925 shares Expires 2033-06-14 Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:32 UTC |
HASTINGS PAUL JDirector
|
GrantCommon Stock | 1,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038023 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,374 F1 · shares: Represents restricted stock units that vest on June 3, 2024, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:26 UTC |
Brege LauraDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,925 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038014 · doc4.xml · derivative · entry 2 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,925 Underlying: Common Stock · 12,925 shares Expires 2033-06-14 Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:26 UTC |
Brege LauraDirector
|
GrantCommon Stock | 1,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038014 · doc4.xml · nonDerivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,322 F1 · shares: Represents restricted stock units that vest on June 3, 2024, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:45 UTC |
WINSTON ROYChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 27,500 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038033 · doc4.xml · derivative · entry 2 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires 2033-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:45 UTC |
WINSTON ROYChief Medical Officer
|
GrantCommon Stock | 10,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038033 · doc4.xml · nonDerivative · entry 1 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,306 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:39 UTC |
RIKER LAURENSenior Vice President, Finance
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038030 · doc4.xml · derivative · entry 5 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-14 F6 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:39 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 7 | $39.01 | $273.07 |
DisclosureSEC source: 0001209191-23-038030 · doc4.xml · nonDerivative · entry 4 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,687 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.000 to $39.010, inclusive. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:39 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 5,773 | $38.52 | $222,375.96 |
DisclosureSEC source: 0001209191-23-038030 · doc4.xml · nonDerivative · entry 3 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,694 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.000 to $38.995, inclusive. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:39 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 586 | $37.47 | $21,957.42 |
DisclosureSEC source: 0001209191-23-038030 · doc4.xml · nonDerivative · entry 2 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,467 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.975 to $37.965, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 5. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:39 UTC |
RIKER LAURENSenior Vice President, Finance
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038030 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,053 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:31 UTC |
GAUGLER DARYLChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038022 · doc4.xml · derivative · entry 2 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:31 UTC |
GAUGLER DARYLChief Operating Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038022 · doc4.xml · nonDerivative · entry 1 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,539 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:34 UTC |
Kronenfeld Mark A.Director
|
GrantStock Option (Right to Buy) · Derivative | 12,925 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038024 · doc4.xml · derivative · entry 2 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,925 Underlying: Common Stock · 12,925 shares Expires 2033-06-14 Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:34 UTC |
Kronenfeld Mark A.Director
|
GrantCommon Stock | 1,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038024 · doc4.xml · nonDerivative · entry 1 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,672 F1 · shares: Represents restricted stock units that vest on June 3, 2024, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:28 UTC |
CHRISTIE CHRISTOPHERDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,925 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001209191-23-038018 · doc4.xml · derivative · entry 2 CHRISTIE CHRISTOPHER · CIK 0001787688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,925 Underlying: Common Stock · 12,925 shares Expires 2033-06-14 Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:28 UTC |
CHRISTIE CHRISTOPHERDirector
|
GrantCommon Stock | 1,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038018 · doc4.xml · nonDerivative · entry 1 CHRISTIE CHRISTOPHER · CIK 0001787688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,261 F1 · shares: Represents restricted stock units that vest on June 3, 2024, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:16 UTC |
Kronenfeld Mark A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $29.90 | $0.00 |
DisclosureSEC source: 0001209191-23-036270 · doc4.xml · derivative · entry 3 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2023-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The option shares vested in 24 equal successive monthly installments over the 24-month period following the date of grant, subject to the reporting person's continued service as a director. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:16 UTC |
Kronenfeld Mark A.Director
|
SaleCommon Stock | 15,000 | $37.04 | $555,600.00 |
DisclosureSEC source: 0001209191-23-036270 · doc4.xml · nonDerivative · entry 2 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,897 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.72 to $37.43, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:16 UTC |
Kronenfeld Mark A.Director
|
Exercise / conversionCommon Stock | 15,000 | $29.90 | $448,500.00 |
DisclosureSEC source: 0001209191-23-036270 · doc4.xml · nonDerivative · entry 1 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 01:32 UTC |
SLONIN JONATHANChief Clinical Officer
|
SaleCommon Stock | 490 | $37.87 | $18,553.85 |
DisclosureSEC source: 0001209191-23-035263 · doc4.xml · nonDerivative · entry 2 SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,323 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.